编辑丨于靖
9月13日,Akero Therapeutics宣布旗下药物Efruxifermin(EFX,曾用名AKR-001)在IIb期HARMONY研究中,可改善肝硬化前期非酒精性脂肪性肝炎(NASH)患者的肝纤维化并防止疾病恶化,Efruxifermin 28mg和50mg剂量组均达到了改善肝脏纤维化的主要终点以及多个次要终点...查看全文
chuminhua2021-08-26 14:55
8月25日,Lipocine公司宣布,其在研疗法LPCN 1144,在治疗非酒精性脂肪性肝炎(NASH)男性患者的2期概念验证临床试验LiFT中获得积极结果。LPCN 1144是一种口服的睾酮前药。NASH是全球肝衰竭和肝移植的主要原因,是非酒精性脂肪性肝病(NAFLD)的一种更晚期状态,可进展为肝硬化,最终发展为肝癌。...查看全文
SnowBall2020Q42021-02-05 22:17
$Lipocine(LPCN)$ 号称口服睾丸酮对于老年男性新冠患者有帮助,但是炒作第一波已经过了。口服治疗方案具体咋样还没有仔细研究。查看全文
$Lipocine Inc.(LPCN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-07 AccNo: 0001144204-18-042231 Size: 4 MB 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-06-29 AccNo: 0001144204-18-036675 Size: 39 KBItem 4.01: Changes in Registrant's Certifying AccountantItem 9.01: Financial Statements and Exhibits 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-06-28 AccNo: 0001144204-18-036342 Size: 29 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-06-13 AccNo: 0001144204-18-034049 Size: 52 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-06-07 AccNo: 0001144204-18-033157 Size: 31 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-05-09 AccNo: 0001144204-18-026332 Size: 34 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-05-07 AccNo: 0001144204-18-025524 Size: 127 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Lipocine Inc.(LPCN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-07 AccNo: 0001144204-18-025522 Size: 3 MB 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-05-07 AccNo: 0001144204-18-025524 Size: 127 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Lipocine Inc.(LPCN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-07 AccNo: 0001144204-18-025522 Size: 3 MB 网页链接